Role of phosphatidylinositol 4,5-bisphosphate in Ras/Rac-induced disruption of the cortactin-actomyosin II complex and malignant transformation.
about
Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domainConditional expression of a truncated fragment of nonmuscle myosin II-A alters cell shape but not cytokinesis in HeLa cellsCortactin signalling and dynamic actin networksHaematopoietic lineage cell-specific protein 1 (HS1) promotes actin-related protein (Arp) 2/3 complex-mediated actin polymerizationCortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex.PI(3,5)P2 controls endosomal branched actin dynamics by regulating cortactin-actin interactions.CLIC4 regulates apical exocytosis and renal tube luminogenesis through retromer- and actin-mediated endocytic traffickingSphingoid base synthesis requirement for endocytosis in Saccharomyces cerevisiae.Molecular features underlying the sequential phosphorylation of HS1 protein and its association with c-Fgr protein-tyrosine kinaseOsmotic stress-induced remodeling of the cortical cytoskeletonThe coiled-coil domain is required for HS1 to bind to F-actin and activate Arp2/3 complex.BetaPix-a enhances the activity of phospholipase Cgamma1 by binding SH3 domain in breast cancer.Hematopoietic lineage cell specific protein 1 associates with and down-regulates protein kinase CK2.Phosphatidylinositol-4,5 bisphosphate produced by PIP5KIgamma regulates gelsolin, actin assembly, and adhesion strength of N-cadherin junctions.Thrombin-induced tyrosine phosphorylation of HS1 in human platelets is sequentially catalyzed by Syk and Lyn tyrosine kinases and associated with the cellular migration of the protein.Myosin 1e is a component of the invadosome core that contributes to regulation of invadosome dynamics.Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemiaVesicle transport: the role of actin filaments and myosin motors.Cytoskeletal tumor suppressors that block oncogenic RAS signaling.Blocking oncogenic Ras signaling for cancer therapy.HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimenDeterminants of the tumor suppressor INPP4B protein and lipid phosphatase activitiesThe identification of a new actin-binding region in p57.PI 4,5-P2 stimulates glucose transport activity of GLUT4 in the plasma membrane of 3T3-L1 adipocytes.The dual effect of Rac2 on phospholipase D2 regulation that explains both the onset and termination of chemotaxisSrc binds cortactin through an SH2 domain cystine-mediated linkage.Cortactin: Coordinating adhesion and the actin cytoskeleton at cellular protrusions.PTP1B: a double agent in metabolism and oncogenesis.INPP4B suppresses prostate cancer cell invasionActin cytoskeleton remodelling in the anterior pituitary folliculostellate cell line TtT/GF: participation of the actin-binding protein cortactin.Ezrin is a Major Regulator of Membrane Tension in Epithelial Cells.Association of a four-amino acid residue insertion polymorphism of the HS1 gene with systemic lupus erythematosus: molecular and functional analysis.Aberrant HS1 molecule in a patient with systemic lupus erythematosus.The anti-RAS cancer drug MKT-077 is an F-actin cross-linker.p85/p110-type phosphatidylinositol kinase phosphorylates not only the D-3, but also the D-4 position of the inositol ring.Myosin IIB deficiency in embryonic fibroblasts affects regulators and core members of the par polarity complex.Ser/Thr phosphorylation of hematopoietic specific protein 1 (HS1)
P2860
Q21266610-7844B6D8-3D2F-4AB8-B782-870A14FF762DQ24290393-5BB0CE91-EF94-46B9-8AE5-507C1B7401C6Q24528115-907EFAD0-2560-44E7-9BBD-2705CC286177Q24529885-27851ED8-CEB2-42C7-AA7A-435A17EF74C7Q24681508-9EA0E463-BE66-4BA3-8ACC-6B5E89BEFE7CQ27310309-70E298A4-E5B3-4923-95A3-834E97102AE7Q27334829-177EFEBF-22B5-4C11-BDBC-98A8DEF05501Q27940229-F1633D01-2CF0-483E-81B3-85C369F6B4A7Q28138224-3A32C787-FCC2-4490-A18C-30DD157B9DB1Q28217767-DC4ACEF4-EA07-4AFB-9A26-9CD0D25FF6A2Q30160134-517C58AE-E4C0-4C61-A0BB-8FFF5E9B16F9Q30160377-CBDE01DA-E788-4CD6-BB2B-802C0C32A389Q30175311-44D2D179-3C8D-4960-878E-581E589319DBQ30479904-637B7145-B4B7-40FC-B3B4-15DA486E67DFQ33292118-869C3C6A-A13D-49B2-8D58-5C74EF06A347Q33604005-462AB9D2-E5BF-487C-868E-C3D07B40FAF6Q33695977-B110A6CB-39D1-4B57-9EA0-0015604C6BEFQ33752884-197295C1-E0BA-4F5E-836B-E69234DC0D2CQ33833348-5883A592-94C9-499E-AB23-02BF13804B07Q34311585-F29C8A0E-FC08-4BED-BF7C-A6843401B7AAQ34328391-79FCEA68-3FD8-4E29-B9C7-426D637DA1B0Q34373594-854EC797-070D-47C6-8503-9B3DB5CF64A6Q34493048-A7E3FC90-9C6B-45E4-971E-03105B053733Q35055046-067FBA77-8B8B-4BB0-A2D5-EB4E94941DF5Q35096291-AC812456-BD95-4D3B-A834-8DF7F079D93DQ36648258-6CB0ED36-F9F9-4712-9DBF-A758DEF957EDQ37479450-B06BE10F-872A-4E68-9734-500FC4127882Q37728307-D90AED64-1FF4-478A-BFF7-21BFA07973E5Q38953956-86F8C790-A133-43B6-B1A4-C2A7EDC5296FQ40274001-C6D9F8DA-7623-4B89-8B9F-F6464881E8A3Q40468734-15A0187C-9C8D-4100-AEAD-AE8CF5D600A0Q40578335-69E81861-F194-4D31-98A7-C8C44A893B58Q40666395-45DCDA67-B4AE-4FE7-A3CF-3A43CDFCE8ACQ40901129-87BDA9E0-2EE8-41EE-943D-504E6BADF5BCQ40939784-F4E6CEBE-0295-4BF5-9703-96A363069542Q44393486-F8F54ECB-63FB-414D-AB6D-770700C12196Q56567057-DBBAFA20-FDBB-4442-BFFE-F42E116D5006
P2860
Role of phosphatidylinositol 4,5-bisphosphate in Ras/Rac-induced disruption of the cortactin-actomyosin II complex and malignant transformation.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Role of phosphatidylinositol 4 ...... and malignant transformation.
@en
Role of phosphatidylinositol 4 ...... and malignant transformation.
@nl
type
label
Role of phosphatidylinositol 4 ...... and malignant transformation.
@en
Role of phosphatidylinositol 4 ...... and malignant transformation.
@nl
prefLabel
Role of phosphatidylinositol 4 ...... and malignant transformation.
@en
Role of phosphatidylinositol 4 ...... and malignant transformation.
@nl
P2093
P2860
P356
P1476
Role of phosphatidylinositol 4 ...... x and malignant transformation
@en
P2093
E Schuuring
T Takenawa
T Watanabe
P2860
P304
P356
10.1128/MCB.18.7.3829
P407
P577
1998-07-01T00:00:00Z